Venkatesan Jay
SEC CIK 1413350 · EDGAR
BoughtSold
Most active insiders at SER, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Moreadith Randall | CSO | — | $501.5K |
| 2 | WILSON KAREN J | Dir | $54.7K | — |
| 3 | Marshall Richard Peter | Dir | $20.1K | — |
| 4 | Brannan Stephen K. | Dir | $2,030 | — |
| 5 | Venkatesan Jay | Dir | $1,048 | — |
| 6 | Bailey Gregory | Dir | — | — |
| 7 | LEDGER STEVEN A | CEO, Dir | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-22 19:15 | 2026-05-22 | SER | Serina Therapeutics, Inc. | Venkatesan Jay | Dir | P - Purchase | $1.78 | +589 | 589 | New | +$1,048 |
| DI | 2026-06-22 19:15 | 2026-06-17 | SER | Serina Therapeutics, Inc. | Venkatesan Jay | Dir | C - Cnv Deriv | $2.25 | +224.2K | 231.7K | +2,968% | +$504.3K |
| 2026-04-21 15:31 | 2026-03-31 | SER | Serina Therapeutics, Inc. | Venkatesan Jay | Dir | A - Grant | $1.94 | +7,553 | 7,553 | New | +$14.7K | |
| D | 2024-11-29 | 2024-11-26 | ELTX | Elicio Therapeutics, Inc. | Venkatesan Jay | Dir | X - OptEx | $0.01 | +50.0K | 179.6K | +39% | +$500 |
| DA | 2022-05-27 | 2021-02-09 | ELTX | Elicio Therapeutics, Inc. | Venkatesan Jay | See Remarks, Dir | X - OptEx | $6.43 | +396.3K | 1.60M | +33% | +$2.55M |
| DA | 2022-05-27 | 2021-02-09 | ELTX | Elicio Therapeutics, Inc. | Venkatesan Jay | See Remarks, Dir | S - Sale+OE | $16.00 | -159.2K | 1.37M | -10% | -$2.55M |
| DA | 2022-05-27 | 2021-02-09 | ELTX | Elicio Therapeutics, Inc. | Venkatesan Jay | See Remarks, Dir | C - Cnv Deriv | $11.57 | +262 | 1.44M | +0.0% | +$3,031 |
| 2022-05-27 | 2022-05-25 | ELTX | Elicio Therapeutics, Inc. | Venkatesan Jay | See Remarks, Dir | P - Purchase | $1.25 | +11.3K | 1.89M | +0.6% | +$14.1K | |
| M | 2022-05-25 | 2022-05-20+ | ELTX | Elicio Therapeutics, Inc. | Venkatesan Jay | See Remarks, Dir | P - Purchase | $1.23 | +82.2K | 1.72M | +5% | +$101.4K |
| M | 2021-12-29 | 2021-12-27+ | ELTX | Elicio Therapeutics, Inc. | Venkatesan Jay | See Remarks, Dir | P - Purchase | $2.63 | +277.2K | 1.64M | +20% | +$730.1K |
| 2021-12-22 | 2021-12-20 | ELTX | Elicio Therapeutics, Inc. | Venkatesan Jay | See Remarks, Dir | P - Purchase | $2.54 | +3,527 | 1.36M | +0.3% | +$8,959 | |
| M | 2021-12-20 | 2021-12-16+ | ELTX | Elicio Therapeutics, Inc. | Venkatesan Jay | See Remarks, Dir | P - Purchase | $2.55 | +41.6K | 1.34M | +3% | +$106.0K |
| 2021-12-17 | 2021-12-15 | ELTX | Elicio Therapeutics, Inc. | Venkatesan Jay | See Remarks, Dir | P - Purchase | $2.41 | +77.6K | 1.32M | +6% | +$187.0K | |
| 2021-12-17 | 2021-06-24 | ELTX | Elicio Therapeutics, Inc. | Venkatesan Jay | See Remarks, Dir | F - Tax | $13.78 | -41.1K | 1.24M | -3% | -$566.2K |
Purchase Sale Sale after option exercise All abbreviations